Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

UKONS 2020 | COVID-19: launching a self-administration service

Fleur Harvey • 19 Nov 2020
UKONS 2020
General Antibodies Bortezomib Cytarabine Trastuzumab

Fleur Harvey, The Royal Marsden NHS Foundation Trust, London, UK, discusses the launch of a self-administration service during COVID-19 with four agents (cytarabine, bortezomib, trastuzumab, denosumab) at the Royal Marsden NHS Foundation Trust. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Fleur Harvey

1:13
COVID-19-mediated streamlining of processes in the UK
Fleur Harvey • 19 Nov 2020

Related Videos

1:56
Phase I trial of trastuzumab deruxtecan and neratinib in HER2-altered tumors
Haeseong Park • 8 Apr 2024
2:45
Remaining challenges in treating solid tumors with CAR-Treg therapy
Leonardo Ferreira • 8 Apr 2024
2:01
Engineering chimeric antigen receptor regulatory T cells for treating cancer
Leonardo Ferreira • 8 Apr 2024
0:59
What challenges are there in using CAR-T cells for solid tumors?
Leonardo Ferreira • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals